Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalamine for Colorectal Cancer Prevention in Lynch Syndrome
NCT04920149Phase 2Recruiting
- Start
- Mar 2022
- Primary completion
- Sep 2032
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Salcrozine in colorectal neoplasm, colorectal cancer (CRC). Started Mar 2022; status: recruiting.
02
Drugs
Salcrozine
03
Conditions
colorectal neoplasmcolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04920149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04920149.